| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
In vivo tumor targeting of a recombinant single-chain antigen-binding protein.
|
J Natl Cancer Inst
|
1990
|
1.61
|
|
2
|
In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
|
J Nucl Med
|
1990
|
1.41
|
|
3
|
Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia.
|
Neurology
|
2002
|
1.24
|
|
4
|
Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia.
|
Trop Med Int Health
|
1998
|
1.24
|
|
5
|
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.
|
Ann Oncol
|
2005
|
1.22
|
|
6
|
Prevalence of epilepsy in rural Bolivia: a door-to-door survey.
|
Neurology
|
1999
|
1.21
|
|
7
|
Presenilin-1-associated abnormalities in regional cerebral perfusion.
|
Neurology
|
2001
|
1.17
|
|
8
|
Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
|
Cancer Res
|
1989
|
1.16
|
|
9
|
Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
|
Cancer Res
|
1988
|
1.12
|
|
10
|
CA 72-4 serum marker--a new tool in the management of carcinoma patients.
|
Cancer Invest
|
1995
|
1.05
|
|
11
|
Mansonella ozzardi infection in Bolivia: prevalence and clinical associations in the Chaco region.
|
Am J Trop Med Hyg
|
1999
|
0.99
|
|
12
|
In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand.
|
Eur J Nucl Med
|
1998
|
0.98
|
|
13
|
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer.
|
Eur J Cardiothorac Surg
|
2001
|
0.97
|
|
14
|
Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.
|
J Natl Cancer Inst
|
1990
|
0.96
|
|
15
|
In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates.
|
Cancer Biother Radiopharm
|
2001
|
0.92
|
|
16
|
Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies.
|
Trans R Soc Trop Med Hyg
|
1995
|
0.90
|
|
17
|
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.
|
Med Oncol
|
2013
|
0.89
|
|
18
|
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
|
Cancer Res
|
2001
|
0.89
|
|
19
|
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation.
|
Int J Cancer
|
1997
|
0.89
|
|
20
|
Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia.
|
Trop Med Int Health
|
1999
|
0.89
|
|
21
|
Prevalence of antibodies to Borrelia burgdorferi, Borrelia parkeri and Borrelia turicatae in human settlements of the Cordillera Province, Bolivia.
|
J Trop Med Hyg
|
1994
|
0.88
|
|
22
|
Chromosome analysis of single- and multipronucleated human zygotes proceeded after the intracytoplasmic sperm injection procedure.
|
J Assist Reprod Genet
|
1996
|
0.87
|
|
23
|
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
|
Clin Cancer Res
|
2001
|
0.87
|
|
24
|
Obesity-driven inflammation and colorectal cancer.
|
Curr Med Chem
|
2012
|
0.86
|
|
25
|
Comparative efficacy of a single 400 mg dose of albendazole or mebendazole in the treatment of nematode infections in children.
|
Trop Geogr Med
|
1993
|
0.86
|
|
26
|
Insulinemia and the risk of breast cancer and its relapse.
|
Diabetes Obes Metab
|
2012
|
0.86
|
|
27
|
Serological survey of leptospiral infections in sheep, goats and dogs in Cordillera province, Bolivta.
|
New Microbiol
|
1997
|
0.85
|
|
28
|
Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer.
|
Int J Biol Markers
|
2003
|
0.84
|
|
29
|
Hospital food: a survey of patients' perceptions.
|
Clin Nutr
|
2003
|
0.84
|
|
30
|
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer.
|
Breast Cancer Res Treat
|
2001
|
0.84
|
|
31
|
CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
|
Cancer Res
|
1992
|
0.84
|
|
32
|
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).
|
Ann Oncol
|
2006
|
0.84
|
|
33
|
Determinants of homocysteine levels in colorectal and breast cancer patients.
|
Anticancer Res
|
2009
|
0.84
|
|
34
|
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
|
Anticancer Res
|
1996
|
0.83
|
|
35
|
Sentinel lymphadenectomy in cutaneous melanoma.
|
Tumori
|
2002
|
0.83
|
|
36
|
Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
|
Cancer
|
1991
|
0.83
|
|
37
|
A probiotics-containing biscuit modulates the intestinal microbiota in the elderly.
|
J Nutr Health Aging
|
2013
|
0.82
|
|
38
|
TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
|
Cancer
|
1993
|
0.82
|
|
39
|
Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
|
Cancer Res
|
1991
|
0.81
|
|
40
|
Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
|
Cancer Res
|
1996
|
0.81
|
|
41
|
Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
|
Lung Cancer
|
2004
|
0.81
|
|
42
|
Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients.
|
Cancer Biomark
|
2009
|
0.80
|
|
43
|
Antimicrobial agent susceptibility patterns of staphylococci isolated in urban and rural areas of Bolivia.
|
J Trop Med Hyg
|
1990
|
0.79
|
|
44
|
Biological effects of a software-controlled voltage pulse generator (PhyBack PBK-2C) on the release of vascular endothelial growth factor (VEGF).
|
In Vivo
|
2005
|
0.79
|
|
45
|
Chelates and antibodies: current methods and new directions.
|
Cancer Treat Res
|
1990
|
0.78
|
|
46
|
Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases.
|
Curr Med Chem
|
2015
|
0.78
|
|
47
|
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation.
|
Anticancer Res
|
2000
|
0.78
|
|
48
|
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
|
Anticancer Res
|
2001
|
0.78
|
|
49
|
Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
|
J Nucl Med
|
1989
|
0.77
|
|
50
|
Effects on platelet function by human interferon-beta in carcinoma patients.
|
Anticancer Res
|
1995
|
0.77
|
|
51
|
Malaria parasitological indices in the Cordillera Province (Santa Cruz Department, Bolivia).
|
Ann Trop Med Parasitol
|
1992
|
0.77
|
|
52
|
Serologic survey for antibodies to Borrelia burgdorferi in sheep, goats and dogs in Cordillera Province, Bolivia.
|
Zentralbl Veterinarmed B
|
1997
|
0.77
|
|
53
|
A neuroepidemiological survey in rural Bolivia: background and methods.
|
Neuroepidemiology
|
1998
|
0.77
|
|
54
|
Pathological classification of DCIS and planning of therapeutic management.
|
Anticancer Res
|
2009
|
0.77
|
|
55
|
Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatonin.
|
Oncol Rep
|
1996
|
0.77
|
|
56
|
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients.
|
Thromb Haemost
|
2011
|
0.77
|
|
57
|
In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: a review.
|
Int J Biol Markers
|
1994
|
0.76
|
|
58
|
Tumor targeting with monoclonal antibody B72.3.
|
Int J Rad Appl Instrum B
|
1989
|
0.76
|
|
59
|
Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma.
|
Int J Cancer
|
1991
|
0.76
|
|
60
|
Minimal sentinel node procedure for staging early breast cancer.
|
Tumori
|
2002
|
0.76
|
|
61
|
Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients.
|
J Surg Oncol Suppl
|
1991
|
0.76
|
|
62
|
Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review).
|
In Vivo
|
1994
|
0.76
|
|
63
|
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience.
|
Support Care Cancer
|
2008
|
0.75
|
|
64
|
Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
|
Anticancer Res
|
1994
|
0.75
|
|
65
|
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis.
|
Am J Pathol
|
1999
|
0.75
|
|
66
|
ICT Filariasis test in patients harbouring Mansonella ozzardi.
|
Trop Med Int Health
|
2000
|
0.75
|
|
67
|
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea.
|
Ann Oncol
|
2011
|
0.75
|
|
68
|
New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma.
|
Int J Rad Appl Instrum B
|
1991
|
0.75
|
|
69
|
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region, Bolivia.
|
Boll Ist Sieroter Milan
|
1989
|
0.75
|
|
70
|
Maintenance of expression of tumor antigens in three-dimensional in vitro human tumor gel-supported histoculture.
|
Anticancer Res
|
1991
|
0.75
|
|
71
|
Novel approaches to tumor detection and therapy using a combination of monoclonal antibody and cytokine.
|
Anticancer Res
|
1996
|
0.75
|
|
72
|
The role of sentinel node biopsy in breast cancer management: an overview.
|
Nucl Med Rev Cent East Eur
|
2000
|
0.75
|
|
73
|
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies.
|
Int J Rad Appl Instrum B
|
1991
|
0.75
|
|
74
|
Evaluation of tumor-associated glycoprotein-72 and CA 125 serum markers in patients with gynecologic diseases.
|
Am J Obstet Gynecol
|
1994
|
0.75
|
|
75
|
Serological survey of toxoplasmosis in the Santa Cruz region of Bolivia.
|
Trans R Soc Trop Med Hyg
|
1990
|
0.75
|
|
76
|
Day-surgical management of ductal carcinoma in situ (DCIS) of the breast using wide local excision with sentinel node biopsy.
|
Tumori
|
2002
|
0.75
|
|
77
|
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy.
|
Cancer Immunol Immunother
|
1987
|
0.75
|
|
78
|
Clinical evaluation of the new tumor marker TAG-72.
|
Anticancer Res
|
1992
|
0.75
|
|
79
|
In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72.
|
Int J Rad Appl Instrum B
|
1991
|
0.75
|
|
80
|
Absence of HIV infection in low- and high-risk groups in the Santa Cruz region, Bolivia.
|
AIDS
|
1989
|
0.75
|
|
81
|
Increased immunogenicity of murine lymphoma cells following exposure to gamma rays in vivo.
|
Chemioterapia
|
1984
|
0.75
|
|
82
|
Response to measles revaccination among Bolivian school-aged children.
|
Trans R Soc Trop Med Hyg
|
1998
|
0.75
|
|
83
|
Radioguided-surgery of early breast lesions.
|
Anticancer Res
|
2001
|
0.75
|
|
84
|
Population movements and cholera spread in Cordillera Province, Santa Cruz Department, Bolivia.
|
Lancet
|
1992
|
0.75
|
|
85
|
[Antibodies against Trichinella spiralis in the rural population of the Province of Cordillera, Bolivia].
|
Rev Panam Salud Publica
|
1999
|
0.75
|
|
86
|
TAG-72 expression and its role in the biological evaluation of human colorectal cancer.
|
Anticancer Res
|
1996
|
0.75
|
|
87
|
Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocols.
|
Int J Biol Markers
|
1991
|
0.75
|
|
88
|
[Intraoperative radiolocalization of intraductal breast carcinoma: sentinel lymph node evaluation].
|
Tumori
|
2003
|
0.75
|
|
89
|
State of the art of sentinel node biopsy in oncology.
|
Tumori
|
2000
|
0.75
|
|
90
|
Regulation of human tumor antigen expression by biological response modifiers (BRMs).
|
Ann Ist Super Sanita
|
1991
|
0.75
|
|
91
|
Prevalence of leptospiral infections in humans in Cordillera Province, Bolivia.
|
Trans R Soc Trop Med Hyg
|
1995
|
0.75
|
|
92
|
Biologic evaluation of tumor-associated glycoprotein-72 and carcinoembryonic antigen expression in colorectal cancer, Part I.
|
Dis Colon Rectum
|
1994
|
0.75
|
|
93
|
Serological survey of antibodies to cytomegalovirus in the Santa Cruz region of Bolivia.
|
J Trop Med Hyg
|
1989
|
0.75
|
|
94
|
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.
|
Anticancer Res
|
1999
|
0.75
|
|
95
|
Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas.
|
J Nucl Med Allied Sci
|
1991
|
0.75
|
|
96
|
[Iron deficiency in an area of Bolivia and high prevalence of intestinal helminthiasis].
|
Parassitologia
|
1990
|
0.75
|
|
97
|
In vitro antimicrobial sensitivity of staphylococci isolated in the Santa Cruz region of Bolivia.
|
Boll Ist Sieroter Milan
|
1989
|
0.75
|
|
98
|
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy.
|
Cancer Immunol Immunother
|
1988
|
0.75
|
|
99
|
Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy.
|
J Thromb Haemost
|
2014
|
0.75
|
|
100
|
Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas.
|
J Surg Oncol Suppl
|
1991
|
0.75
|
|
101
|
Preoperative neuroimmunotherapy with subcutaneons low-dose interleukin-2 and melatonin in patients with gastrointestinal tumors - its efficacy in preventing surgery-induced lymphocytopenia.
|
Oncol Rep
|
1995
|
0.75
|
|
102
|
Prevalence of antibody to hepatitis A virus in the Santa Cruz region of Bolivia.
|
J Trop Med Hyg
|
1989
|
0.75
|
|
103
|
Improved experimental radioimmunotherapy of colon xenografts by combining 131I-CC49 and interferon-gamma.
|
Dis Colon Rectum
|
1994
|
0.75
|
|
104
|
[Ductal carcinoma in situ (DCIS): an always present reality; which treatment? Role of sentinel lymph node].
|
Suppl Tumori
|
2002
|
0.75
|
|
105
|
Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
|
J Trop Med Hyg
|
1994
|
0.75
|